University of Pittsburgh Announces Six Patents Issued to Pitt innovators in April 2023

Pitt innovators were issued six patents in April 2023.

Featured Patent: 11,623,004: “Compositions and Methods for Vaccination Against Respiratory Syncytial Virus Infection”

Respiratory syncytial virus (RSV) infects most children before their second birthday. In the US, the virus hospitalizes more than 100,000 children and infants each year, and these severe infections during infancy can lead to asthma later on. Past attempts to vaccinate against RSV have been ineffective because of poor antibody production by the infant’s immature immune system. Even worse — for reasons that remain unclear — direct infant vaccination with some immunogens heightens the risk of a severe respiratory illness called vaccine-enhanced respiratory disease (VERD). A team of Pitt innovators is taking a novel approach combining an existing vaccine candidate for RSV, currently in clinical trials, with an adjuvant to boost antibody formation. This regimen is designed for a pregnant woman to receive during pregnancy.

For more information on this technology, including licensing, contact Andrew Remes at aremes@innovation.pitt.edu.

Below is a listing of all patents issued to Pitt innovators in April 2023. You can also search all available Pitt technologies.